Browse articles from EyeWorld.org related to presbyopia. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Positive topline results for Phase 3 trial of drug for allergic conjunctivitis
➤ Phase 2 trial of progesterone topical gel for DED begins
➤ Breakthrough Device Designation granted to remote glaucoma management system
➤ Glaukos enters into licensing agreement for presbyopia treatment
➤ Increase in laser vision correction procedures continues
➤ Guide on climate change and eye health
➤ ASCRS events
➤ FDA accepts IND for presbyopia-correcting eye drop
➤ Pivotal study of new tech against gold standard patching treatment of amblyopia
➤ Topline results from trial to reverse pharmacologically induced mydriasis
➤ Pivotal study of fixed-combination tropicamide/phenylephrine product for mydriasis
➤ ASCRS introduces new Richard L. Lindstrom Lecture
➤ FDA accepts NDA for fixed-combination mydriatic agent
➤ NDA accepted by FDA for dry eye nasal spray
➤ NDA submitted for drop to treat presbyopia
➤ Study to assess outcomes of ab interno canaloplasty
➤ Largest study of glaucoma genetics published
➤ Iridex and Topcon enter into strategic agreement
➤ COVID-19 vaccine update
➤ ASCRS Journal Club on March 11
➤ PMA submitted to FDA for small-aperture IOL
➤ Preclinical results for new class of non-prostaglandin analogs for IOP lowering
➤ A Phase 2 clinical trial begins enrollment for topical presbyopia-correcting drop
➤ Home OCT technology used in clinical trial to reduce participant visits to offices
➤ ASCRS Journal Club on March 11
Patients often seek their ophthalmologist’s expert opinion for the IOL they would recommend if they were in the patient’s situation. As a resident at Northwestern University, Hercules Logothetis, MD, and his mentor Robert Feder, MD, actually asked ophthalmologists about the technology they would choose for themselves.1
Monovision is a proven and trustworthy option to attain spectacle independence in patients undergoing cataract surgery. According to Ehud Assia, MD, the best results are attained by waiting for the outcomes of the first-eye surgery before moving on the create monovision.
Refractive lens exchange is a growing treatment option in the U.S., with hyperopic presbyopes over age 50 being the ideal candidates. Physicians stress the importance of patient education for this procedure.
ReSTOR lens
Source: Alcon
Ever since their conception, multifocal intraocular lenses (IOLs) have been measured against their predecessor, monofocal lenses. With the appearance of accommodating lenses on the market in recent years, inevitable comparisons are now being drawn between multifocal lenses and the latest advancement in IOL technology. EyeWorld takes a look at the pros and cons of the lenses.
